Immunovant

$15.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-2.36%) As of 7:44 PM UTC today

Why Robinhood?

You can buy or sell Immunovant and other stocks, options, and ETFs commission-free!

About IMVT

Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company.

CEO
Peter Salzmann
Employees
—
Headquarters
New York, New York
Founded
2018
Market Cap
1.48B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
721.01K
High Today
$15.51
Low Today
$15.11
Open Price
$15.51
Volume
258.78K
52 Week High
$53.75
52 Week Low
$11.80

IMVT Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jun 28, Pre-Market

You May Also Like

XOMA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure